alexa Hepatitis B Reactivation in Patients with Hematological
ISSN: 2165-7831

Journal of Blood & Lymph
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Hepatitis B Reactivation in Patients with Hematological Malignancies and Stem Cell Transplantation

Nishitha M Reddy* and Bipin N Savani

Section of Hematology and Stem Cell Transplantation, Division of Hematology/ ncology, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA

*Corresponding Author:
Nishitha Reddy
Division of Hematology and Oncology
Department of Medicine
Vanderbilt University Medical center
1301 Medical Center Drive; 3927 TVC
TN-37232, Nashville, USA
Tel: 615-936-0381
Fax: 615-936-1812
E-mail: [email protected]

Received Date: July 27, 2013; Accepted Date: December 26, 2013; Published Date: December 30, 2013

Citation: Reddy NM, Savani BN (2013) Hepatitis B Reactivation in Patients with Hematological Malignancies and Stem Cell Transplantation. J Blood Lymph 4:114. doi: 10.4172/2165-7831.1000114

Copyright: © 2013 Reddy NM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Hepatitis B infection is the leading cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma and is thought to be responsible for million deaths per year globally. Management of patients with resolved or active hepatitis B and cancer is a challenge and these patients are at higher risk of hepatitis B related complications due to immunosuppression and loss of prior immunity. The treating hematologist needs to understand the biology of this common virus, its potential for long-term harm, the necessary laboratory monitoring for their identification and characterization, and the pharmacological interventions for their control. This review offers a general approach to prevention and treatment of hepatitis B reactivation in patients with hematological malignancies and transplant recipients. Practitioners are also encouraged to seek advice and consultation from experts in the design of specific protocols for screening, monitoring and prevention.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version